COMMENTARY Mercury Neurotoxicity in Rats and Humans Emphasizes Current Trends in Neurotoxicology
This issue of Toxicologic Pathology contains two review articles on mercury neurotoxicity by noted Japanese experts. The paper by Eto, entitled &dquo;The Pathology of Minimata Disease,&dquo; provides a thorough summary of the epidemiology and pathology of mercury neurotoxicity in humans. The complementary paper by Nagashima, &dquo;A Review of Experimental Methylmercury Toxicity in Rats: Neuropathology and Evidence for Apoptosis,&dquo; summarizes experimental rodent data and presents information supporting an apoptotic mechanism for the cerebellar effects of mercury. Not only do these reviews illustrate the use of experimental models to study neurotoxicity, they also summarize data using special procedures to explore pathogenic mechanisms. After realizing the human costs of epidemic toxicities such as Minimata disease and others (5, 6) , we begin to understand at least part of the basis for the current regulatory interest in neurotoxicology.
Neurotoxicology is an emerging area of importance in safety assessment studies performed by industry for approval of products (4) . Recently, regulatory agencies have increased the expectation for detailed evaluation of the nervous system in test animals. This has been driven largely by the United States Environmental Protection Agency (EPA), the Organization for Economic Cooperation and Development (OECD), and the Food and Drug Administration's Center for Food and Applied Nutrition (CFSAN). New guidelines exist in draft or final versions from each of these groups (21, 39, 43, 44) and are directed more toward the testing of chemicals and food additives than pharmaceuticals. In general, the new guidelines ask for complex behavioral test batteries and, in some cases, detailed neuropathology evaluations. Although it is not possible to define all the factors that led to the evolution of these new guidelines for neurotoxicity testing, concern about the potential involvement of environmental toxicants in the pathogenesis of human neurodegenerative diseases is certainly among the important issues (16, 19, 23, 41) .
One of the major topics of current concern in environmental toxicology is the area of heavy metals (37) . Although certain metals are known to have toxic effects in many different organs, the nervous system is a wellknown target in both adults and children (7, 46) . Given this, it is not surprising that many recent textbooks contain extensive reviews of metal neurotoxicology (2, 8, 9, 22) , and the 1997 Annual Meeting of the Society of Toxicology featured several sessions on the subject (see &dquo;The Toxicologist,&dquo; Fundamental and Applied Toxicology 36 [1] , 1997). Major neurotoxic metals include mercury, lead, arsenic, cadmium, aluminum, manganese, and various tin compounds. Of these, mercury has had a devastating impact on human health and is the subject of two review articles in this issue of Toxicologic Pathology.
The paper by Eto (18) provides a comprehensive review of Minimata disease, a disease that originated in Japan in the 1950s and resulted in an epidemic. The cause was methylmercury contamination in fish and seafood. Several other similarly devastating environmental mercury poisonings have occurred since the tragedy in Minimata Bay, and there is current concern about mercury contamination in mining areas from the Amazon river basin. Eto reviews the epidemiology and pathology of mercury neurotoxicity in adults and infants while explaining the differences between organic and inorganic mercury toxicities. In addition, the author presents interesting findings using the histochemical technique of autometallography (AMG) to locate mercury deposits in postmortem tissues (liver, kidney, and brain) of affected humans. AMG is a powerful technique that provides detailed light and electron microscopic information on the precise cellular location of certain metals and metal sulfides and selenides (12, 32, 35, 36) . Using this highly sensitive technique, metals in tissue can be visualized after catalyzing the reduction of silver nitrate in a developing solution (13, 14) . Since AMG identifies the presence of metal in tissue but cannot definitively identify that metal, the technique is particularly suited for research studies. For example, AMG has been used to reveal the location of mercury in the brain of rats (26) and monkeys (10) under experimental conditions. Data summarized by Eto from AMG studies in human cases of mercury toxicity demonstrate the presence of mercury in neurons and glial cells. These observations have allowed the author to hypothesize possible cellular and subcellular routes for mercury as it moves through the brain. Since glial cells are now recognized as playing a major role in neural function (1, 33) and perturbation of normal glial-neuronal homeostasis may have direct relevance to mechanisms of neurotoxicity (24, 42) , the presence of mercury in glial cells may be involved directly in the pathogenesis of this neurotoxicity. Interestingly, there is in vitro (3) and in vivo (10) evidence that mercury is sequestered in astrocytes, where it has been shown recently to inhibit the normal uptake of certain neurotransmitters such as serotonin and glutamate (15) . Alteration in neurotransmitter homeostasis, especially dysregulation of glutamate, could be a mechanism for mercury neurotoxicity.
In fact, many neurotoxic metals have been shown to have adverse effects on glutamate homeostasis (16) .
Evidence for the effect of metals on astrocytes is not limited to mercury, as recent data also implicates lead (30, 40) and cadmium (40) in affecting astrocytic function. Moreover, effects on other functionally important neuroglia, such as the microglial cell, have been reported for both trimethyltin (27) and mercury (11) . The latter study documented a 165% increase in the number of microglia in mercury-exposed monkeys.
In the companion paper on mercury toxicity, Nagashima reviews certain aspects of experimental administration of mercury to rats (28) . Specifically, the author describes the pathology of methylmercury toxicity in peripheral nerves, sensory ganglia, spinal cord, cerebrum, and cerebellum. As Eto did with AMG in the human cases, Nagashima uses special procedures to expand our understanding of mercury neurotoxicity. For example, effects in nerves and spinal nerve roots are clearly demonstrated by immunohistochemical staining for neurofilament protein. Neurofilaments are highly phosphorylated intermediate filaments in neurons (29) that can exhibit altered phosphorylation states in certain disease conditions in vivo (25) and with in vitro exposure to methylmercury (38) . Nagashima also uses immunohistochemistry with an antibody to ED1, which recognizes a cytoplasmic antigen in rat macrophages (17) and demonstrates a generalized phagocytic reaction to nerve fiber destruction. Other in vivo studies have shown similar results after drug-induced nervous system injury (45) . Collectively, these data show how multiple approaches can help confirm the cellular response to degeneration in the nervous system. Nagashima uses findings from rat experiments to contrast the pathology of mercury toxicity in humans and nonhuman primates with that of rodents, concluding that effects in the visual cortex predominate in primates but cerebellar effects exist in all species. Cerebral effects apparently do not occur in rats as they do in humans.
Perhaps most striking in Nagashima's review are the relatively selective effects of methylmercury neurotoxicity in cerebellar granule cells, with the Purkinje cells relatively spared. Moreover, this selective granule cell loss appears to occur through an apoptotic mechanism, which the author illustrates with transmission electron microscopy and positive in situ nick end-labeling (TU-NEL) staining. To confirm the hypothesized apoptotic pathway, electrophoresis of cerebellar homogenates from methylmercury-treated rats reveals a typical 200-basepair DNA ladder pattern. Apoptotic mechanisms for cell death in the nervous system are known to exist for other toxins (20, 31) and are beginning to be considered important in various neurodegenerative diseases (31, 34) .
The readership of Toxicologic Pathology is fortunate to have two companion review articles that address complementary aspects of mercury toxicity. However, these articles bring us more than current information on mercury. By considering them broadly, we recognize the direct connection between experimental toxicologic pathology and human neurotoxic disease. Moreover, we gain a better appreciation of how our discipline benefits society. 
